Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

HC Wainwright & Co. Maintains Buy on Checkpoint Therapeutics, Adjusts Price Target to $76 – 1-for-10 Reverse Stock Split

HC Wainwright & Co. analyst Joseph Pantginis maintains Checkpoint Therapeutics (NASDAQ:CKPT) with a Buy, adjusts price target to $76 – 1-for-10 reverse stock split.
byBenzinga Newsdesk
December 23, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

HC Wainwright & Co. analyst Joseph Pantginis maintains Checkpoint Therapeutics (NASDAQ:CKPT) with a Buy, adjusts price target to $76 – 1-for-10 reverse stock split.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts